The Food and Drug Administration Advisory panel approved the Pfizer-BioNTech COVID-19 vaccine Dec. 10, greenlighting vaccination efforts for priority groups including frontline health care workers, pharmacists and residents at long-term care facilities, the American Pharmacists Association reports. Read More »

Newly launched CPhT-Adv credential supports the expanded roles of the most valuable players on the pharmacy team Read More »

Highlights Lincoln International's leading advisory position in the animal health sector Read More »

The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration's approval of the first Emergency use Authorization for the COVID-19 vaccine. Read More »

Action from the U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) has been challenged by the Pharmaceutical Research and Manufacturers of America (PhRMA), Partnership for Safe Medicines (PSM) and Council for Affordable Health Coverage (CAHC) for letting drugs from Canada into the country without the authorization of manufacturers' oversight. Read More »

PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals, the leading RNAi therapeutics company, as a very limited distribution pharmacy partner for new drug OXLUMO™ (lumasiran). Read More »

The U.S. Food and Drug Administration (FDA) approved the first drug to be used for positron emissions tomography (PET) imaging for prostate cancer on Dec. 1. Read More »

Orsini Specialty Pharmacy, a leader in rare diseases and gene therapies, announced that it has been selected by Alnylam® Pharmaceuticals as a limited distribution partner for OXLUMO™ (lumasiran). Read More »

Researchers recently dove into the complex answer behind the question of whether or not the United States or China holds more influence in the Indo-Pacific Region, according to a research brief from the RAND Corporation. Read More »

The AZD1222 COVID-19 vaccine has shown positive early results, according to Astra Zeneca. Read More »

Vivera Pharmaceuticals and Burkhan World today announce financial backing by JR Dallas Wealth Management in support of Vivera's global growth strategies. Read More »

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Tuesday, December 1, at 4:20 PM ET. Read More »

endpoint Clinical, the leading global interactive response technology (IRT®) company, and McCreadie Group, the market leader in automating manual processes in Investigational Drug Services (IDS), have collaborated to increase study product accountability transparency for study sponsors, reduce site burdens associated with clinical study IMP management, and improve related data integrity via carefully balanced interfacing of McCreadie's site-based Vestigo® application and endpoint's PULSE® IRT. Read More »

The Food and Drug Administration announced Fresh Express is recalling limited numbers of its Caesar Supreme kit over concerns of E. coli STEC 026 contamination, according to a press release. Read More »

Amazon has now launched an online pharmacy to serve as competition for other big-named retail pharmacies, according to a news release. Read More »

RedSail Technologies, LLC, has signed an agreement to acquire PioneerRx, LLC. The transaction is currently undergoing a standard regulatory review and will close upon receipt of approval. Read More »

Tool builds trust, creates an enhanced member experience Read More »

Cardinal Health (NYSE: CAH) has reached an agreement with the Centers for Disease Control and Prevention (CDC) to act as a network administrator in Phase 2 of the Federal Pharmacy Partnership Strategy for COVID-19, which will enable retail independent, small chains and long-term care pharmacy customers to participate in the vaccination effort. Read More »

Federal agencies are coordinating efforts to prevent items that they have designated as a public health threat from entering the country. Read More »

The Food and Drug Administration (FDA) confirmed that all dispensers such as pharmacies will have to meet requirements that go into effect on Friday, Nov. 27, regardless of the American Pharmacists Association's (APhA) concerns that not all of the Drug Supply Chain Security Act requirements are undermined by COVID-19 pandemic responses. Read More »